DW71177 |
Catalog No.GC71490 |
DW71177는 소설 [1,2,4] 트리아졸로 [4,3-a] 퀴녹살린 기반 강력 및 bd1-선택적 BET 억제제이며 급성 골수성 백혈병 연구에 사용할 수 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2241311-72-6
Sample solution is provided at 25 µL, 10mM.
DW71177 is a novel [1,2,4]triazolo[4,3-a] quinoxaline-based potent and BD1-Selective BET inhibitor, and can be used for study of acute myeloid leukemia.
References:
[1]. Ali I, et al. DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia. Eur J Med Chem. Published online December 16, 2023.
Review for DW71177
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for DW71177
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *